Yan Gong

5.5k total citations · 1 hit paper
160 papers, 3.3k citations indexed

About

Yan Gong is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yan Gong has authored 160 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Molecular Biology, 33 papers in Oncology and 33 papers in Cancer Research. Recurrent topics in Yan Gong's work include RNA modifications and cancer (23 papers), Cancer-related molecular mechanisms research (17 papers) and Ferroptosis and cancer prognosis (16 papers). Yan Gong is often cited by papers focused on RNA modifications and cancer (23 papers), Cancer-related molecular mechanisms research (17 papers) and Ferroptosis and cancer prognosis (16 papers). Yan Gong collaborates with scholars based in China, United States and Sweden. Yan Gong's co-authors include Conghua Xie, Linzhi Han, Gaosong Wu, Qiuxia Cui, Deguang Kong, Jianing Tang, Lois E. H. Smith, Zhongjie Fu, Dan Zhang and Zhengrong Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Yan Gong

154 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mechanisms and management of 3rd‑generation EGFR‑TKI resistance in advanced non‑small cell lung cancer (Review)

2021 193 citations Zhengrong Huang, Linzhi Han et al. profile →

Peers

Yan Gong

PRM

ONCOL

IMMUN

Fan Zhang China

Judy R. van Beijnum Netherlands

Jiän Zhang China

Arash Salmaninejad Iran

Pedro Miguel Lacal Italy

Melissa L. Fishel United States

Akira Saito Japan

Yusheng Wang China

Martin Highley United Kingdom

Yoshihito Shima Japan

Fan Zhang China

Yan Gong

1.9k ×1.1

640 ×1.0

PRM

741 ×1.2

1.1k ×1.8

ONCOL

554 ×1.1

IMMUN

Citations per year, relative to Yan Gong Yan Gong (= 1×) peers Fan Zhang

Countries citing papers authored by Yan Gong

Since Specialization

Citations

This map shows the geographic impact of Yan Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Gong more than expected).

Fields of papers citing papers by Yan Gong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Gong. The network helps show where Yan Gong may publish in the future.

Co-authorship network of co-authors of Yan Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Gong. A scholar is included among the top collaborators of Yan Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Gong. Yan Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Han, Linzhi, Ji Qian, Xiuli Guo, et al.. (2025). Radiotherapy in combination with PD-1 and TIGIT blockade mediate antitumor abscopal effects and immune memory via CD8+ T cells. Cancer Letters. 631. 217935–217935. 1 indexed citations

Yao, Xiangyang, Haoran Liu, Chen Duan, et al.. (2025). Sirtuin1 mitigation of calcium oxalate nephropathy via enhancing itaconate abundance through reduction of histone trimethylation. Clinical and Translational Medicine. 15(8). e70450–e70450.

Chen, Xinyi, Rui Wang, Yan Gong, et al.. (2024). Reactive oxygen species-responsive coating based on Ebselen: Antioxidation, pro-endothelialization and anti-hyperplasia for surface modification of cardiovascular stent. Colloids and Surfaces B Biointerfaces. 245. 114314–114314. 3 indexed citations

Gong, Yan, Tao Gan, Jian‐Guo Zhang, et al.. (2024). Targeting the LMP1‐ALIX axis in EBV ⁺ nasopharyngeal carcinoma inhibits immunosuppressive small extracellular vesicle secretion and boosts anti‐tumor immunity. Cancer Communications. 44(12). 1391–1413. 4 indexed citations

Li, Bo, Haoran Liu, Yangjun Zhang, et al.. (2024). Sirtuin1 Suppresses Calcium Oxalate Nephropathy via Inhibition of Renal Proximal Tubular Cell Ferroptosis Through PGC‐1α‐mediated Transcriptional Coactivation. Advanced Science. 11(48). e2408945–e2408945. 9 indexed citations

Liu, Xingyu, Jiali Li, Zihang Zeng, et al.. (2023). Integrated analysis reveals common DNA methylation patterns of alcohol-associated cancers: A pan-cancer analysis. Frontiers in Genetics. 14. 1032683–1032683. 3 indexed citations

Qu, Meihua, Yanhua Xu, Wenjie Sun, et al.. (2023). hsa-miR-1301-3p Promotes the Proliferation and Migration of Nonsmall Cell Lung Cancer Cells and Reduces Radiosensitivity via Targeting Homeodomain-Only Protein Homeobox. Genetic Testing and Molecular Biomarkers. 27(12). 393–405.

Ren, Jiangbo, et al.. (2022). Long-Chain Polyunsaturated Fatty Acids and Their Metabolites Regulate Inflammation in Age-Related Macular Degeneration. SHILAP Revista de lepidopterología. 22 indexed citations

Han, Linzhi, Hongjie Shi, Shijing Ma, et al.. (2022). Agrin Promotes Non-Small Cell Lung Cancer Progression and Stimulates Regulatory T Cells via Increasing IL-6 Secretion Through PI3K/AKT Pathway. Frontiers in Oncology. 11. 804418–804418. 21 indexed citations

10.

Liu, Xingyu, Qiuji Wu, Xueping Jiang, et al.. (2021). Systematic Analyses of a Chemokine Family-Based Risk Model Predicting Clinical Outcome and Immunotherapy Response in Lung Adenocarcinoma. Cell Transplantation. 30. 4211112902–4211112902. 4 indexed citations

11.

Sun, Yingming, Xiaoge Sun, Shijing Ma, et al.. (2021). MUC3A promotes non-small cell lung cancer progression via activating the NFκB pathway and attenuates radiosensitivity. International Journal of Biological Sciences. 17(10). 2523–2536. 12 indexed citations

12.

Chen, Sichao, Zeming Liu, Man Li, et al.. (2020). Potential Prognostic Predictors and Molecular Targets for Skin Melanoma Screened by Weighted Gene Co-expression Network Analysis. Current Gene Therapy. 20(1). 5–14. 11 indexed citations

13.

Tang, Jianing, Jiangbo Ren, Qiuxia Cui, et al.. (2019). A prognostic 10‐lncRNA expression signature for predicting the risk of tumour recurrence in breast cancer patients. Journal of Cellular and Molecular Medicine. 23(10). 6775–6784. 16 indexed citations

14.

Zhang, Weijia, et al.. (2019). Radiotherapy activates autophagy to increase CD8 ⁺ T cell infiltration by modulating major histocompatibility complex class-I expression in non-small cell lung cancer. Journal of International Medical Research. 47(8). 3818–3830. 33 indexed citations

15.

Cheng, Yuan, Rui Bai, Yanping Gao, et al.. (2019). MiR-195 restrains lung adenocarcinoma by regulating CD4+ T cell activation via the CCDC88C/Wnt signaling pathway: a study based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and bioinformatic analysis. Annals of Translational Medicine. 7(12). 263–263. 16 indexed citations

16.

Liu, Yalei, Yuan Li, Yan Gong, et al.. (2017). CD26 expression is down-regulated on CD8+ T cells in patients with Hashimoto's thyroiditis. International Immunopharmacology. 54. 280–285. 10 indexed citations

17.

He, Qing, et al.. (2016). Sef Regulates Epithelial‐Mesenchymal Transition in Breast Cancer Cells. Journal of Cellular Biochemistry. 117(10). 2346–2356. 23 indexed citations

18.

Liu, Yalei, Ran You, Nan Yu, et al.. (2016). Increased proportions of Tc17 cells and NK cells may be risk factors for disease progression in Hashimoto's thyroiditis. International Immunopharmacology. 40. 332–338. 15 indexed citations

19.

Liu, Yalei, Yan Gong, Ran You, et al.. (2016). CD32b expression is down-regulated on double-negative memory B cells in patients with Hashimoto's thyroiditis. Molecular and Cellular Endocrinology. 440. 1–7. 9 indexed citations

20.

Yang, Xuehui, Yan Gong, Yuefeng Tang, et al.. (2013). Spry1 and Spry4 Differentially Regulate Human Aortic Smooth Muscle Cell Phenotype via Akt/FoxO/Myocardin Signaling. PLoS ONE. 8(3). e58746–e58746. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact